Araceli Biosciences Inc.
New Filing
CIK: 0001975014·Other Technology·DELAWARE·Filed: Nov 3, 2026
Total Offering
$4,500,000
Amount Sold
$2,526,065
Investors
4
First Sale
Oct 20, 2026
Offering Details
- Type
- Debt, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2022
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Matt Beaudet | Related Person |
| Shawn MacDonald | Related Person |
| William Cortelyou | Related Person |
| J. William Freytag | Related Person |
| Kirk Malloy | Related Person |
| Sean O'Neill | Related Person |
| Samraat Raha | Related Person |
| Bruce Rhine | Related Person |
| Christine Ann Tsingos | Related Person |
Company
SEC Filing
0001975014-26-000004
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free